{"entity":{"id":"944184c2-072e-52fa-a2ba-e05d6586126b","name":"TRUEX PAUL F","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001120362","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"subsidiary":{"id":"a6f815dd-2ef6-55ab-85ab-7f99a8cc3977","name":"Milestone Pharmaceuticals Inc.","type":"Company","kind":"company","identifier":"sec:0001408443"}},{"role":"director","share":null,"subsidiary":{"id":"806e93a3-924a-5417-98bd-577b36ac2646","name":"CYMABAY THERAPEUTICS, INC.","type":"Company","kind":"company","identifier":"sec:0001042074"}},{"role":"director","share":null,"subsidiary":{"id":"e045f694-438c-5a8e-85e4-8681774f40b6","name":"ANTHERA PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001316175"}},{"role":"officer","share":null,"subsidiary":{"id":"e045f694-438c-5a8e-85e4-8681774f40b6","name":"ANTHERA PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001316175"}},{"role":"director","share":null,"subsidiary":{"id":"c004085a-f284-5a30-8fa6-7a56558e8fa1","name":"RX3 PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001356857"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}